Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CK Life Sciences Int'l., (Holdings) Inc. Proxy Solicitation & Information Statement 2009

Apr 14, 2009

49461_rns_2009-04-14_9a669114-0ce7-466d-8d5d-c945a6cad268.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [218 x 31] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 0775)

PROXY FORM FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING

I/We[(a)] of being the registered holder(s) of[(b)] shares of HK$0.10 each of CK Life Sciences Int’l., (Holdings) Inc. (the “Company”) hereby appoint[(c)] the Chairman of the meeting or of or failing him of

to act as my/our proxy to attend, act and vote on my/our behalf as directed below at the Annual General Meeting of the Company to be held at the Ballroom, 1st Floor, Harbour Plaza Hong Kong, 20 Tak Fung Street, Hung Hom, Kowloon, Hong Kong on Monday, 18 May 2009 at 10:00 a.m. and at any adjournment thereof.

Please indicate with a “ x ” in the spaces provided how you wish your vote(s) to be cast on a poll. Should this proxy form be returned duly signed but without a specific direction, the proxy will vote or abstain at his discretion.

FOR AGAINST

  1. To receive the audited Financial Statements, the Report of the Directors and the Independent Auditor’s Report for the year ended 31 December 2008.

  2. (1) To elect Mr. Peter Peace Tulloch as Director. (2) To elect Professor Wong Yue-chim, Richard as Director.

  • (3) To elect Mrs. Kwok Eva Lee as Director.

    1. To appoint Messrs. Deloitte Touche Tohmatsu as Auditor and authorise the Directors to fix their remuneration.
    1. (1) Ordinary Resolution No. 4(1) of the Notice of Annual General Meeting (To give a general mandate to the Directors to issue additional shares of the Company).
  • (2) Ordinary Resolution No. 4(2) of the Notice of Annual General Meeting (To give a general mandate to the Directors to repurchase shares of the Company).

  • (3) Ordinary Resolution No. 4(3) of the Notice of Annual General Meeting (To extend the general mandate granted to the Directors pursuant to Ordinary Resolution No. 4(1) to issue additional shares of the Company).

  1. Special Resolution of the Notice of Annual General Meeting (To approve the amendments to the Memorandum and Articles of Association of the Company).

Dated the day of 2009.

Shareholder’s Signature: Witness:

Notes:

  • (a) Full name(s) and address(es) to be inserted in BLOCK CAPITALS .

  • (b) Please insert the number of shares registered in your name(s). If no number is inserted, this proxy form will be deemed to relate to all the shares in the capital of the Company registered in your name(s).

  • (c) Any member entitled to attend and vote at the Annual General Meeting is entitled to appoint more than one proxy to attend and on a poll, vote in his stead. A proxy need not be a member of the Company.

  • (d) In the case of joint holders, this proxy form must be signed by the member whose name stands first on the Register of Members of the Company.

  • (e) This proxy form must be signed by the appointor, or his attorney duly authorised in writing, or if such appointor be a corporation, either under its Common Seal or under the hand of an officer, attorney or other person so authorised.

  • (f) To be valid, this proxy form together with any power of attorney or other authority (if any) under which it is signed or a notarially certified copy of such power or authority must be deposited at the Company’s principal place of business at 7th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong not later than 48 hours before the time appointed for holding the Annual General Meeting or any adjournment thereof (as the case may be).

  • (g) Any alterations made in this proxy form should be initialled by the person who signs it.

  • (h) The Notice of Annual General Meeting is set out in the Company’s circular dated 15 April 2009.

7th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong